Ovoca Bio (OVB) Competitors

GBX 0.82
0.00 (0.00%)
(As of 04/25/2024 ET)

OVB vs. PYC, NFX, EVG, APTA, FAB, OCTP, IXI, VAL, BSFA, and GENF

Should you be buying Ovoca Bio stock or one of its competitors? The main competitors of Ovoca Bio include Physiomics (PYC), Nuformix (NFX), Evgen Pharma (EVG), Aptamer Group (APTA), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.

Ovoca Bio vs.

Physiomics (LON:PYC) and Ovoca Bio (LON:OVB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

In the previous week, Ovoca Bio's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Ovoca Bio Neutral

Physiomics has higher revenue and earnings than Ovoca Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£900.71K2.16N/AN/AN/A
Ovoca BioN/AN/A-£2.33M-£0.02-41.25

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Physiomics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ovoca Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Physiomics has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Ovoca Bio has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

Physiomics received 63 more outperform votes than Ovoca Bio when rated by MarketBeat users. However, 70.83% of users gave Ovoca Bio an outperform vote while only 55.56% of users gave Physiomics an outperform vote.

CompanyUnderperformOutperform
PhysiomicsOutperform Votes
80
55.56%
Underperform Votes
64
44.44%
Ovoca BioOutperform Votes
17
70.83%
Underperform Votes
7
29.17%

Ovoca Bio has a net margin of 0.00% compared to Ovoca Bio's net margin of -70.32%. Physiomics' return on equity of -33.98% beat Ovoca Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-70.32% -62.94% -37.22%
Ovoca Bio N/A -33.98%-4.89%

0.1% of Physiomics shares are owned by institutional investors. 6.3% of Physiomics shares are owned by insiders. Comparatively, 48.4% of Ovoca Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Physiomics and Ovoca Bio tied by winning 5 of the 10 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OVB vs. The Competition

MetricOvoca BioBiotechnology IndustryMedical SectorLON Exchange
Market Cap£673,000.00£204.75M£4.86B£1.40B
Dividend Yield0.83%3.48%2.97%12.02%
P/E Ratio-41.25237.63201.391,730.47
Price / SalesN/A13,355.522,455.78329,037.96
Price / Cash1.0011.1546.8932.90
Price / Book0.145.494.592.47
Net Income-£2.33M-£31.74M£103.13M£180.16M
7 Day Performance13.79%-0.03%-0.23%0.82%
1 Month Performance-11.58%-3.64%-5.74%8.93%
1 Year Performance-85.00%48.23%8.60%16.77%

Ovoca Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
0 of 5 stars
GBX 1.20
flat
N/A-51.0%£1.63M£900,707.00-13.8310Gap Down
NFX
Nuformix
0 of 5 stars
GBX 0.21
flat
N/A-22.0%£1.68M£50,000.00-1.633Gap Up
EVG
Evgen Pharma
0 of 5 stars
GBX 0.78
flat
N/A-79.0%£2.13MN/A-77.5010Gap Up
APTA
Aptamer Group
0 of 5 stars
GBX 0.53
flat
N/A-96.9%£2.45M£1.03M-6.5637Gap Up
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.80
-2.6%
N/A-89.4%£3.62M£1.58M-42.2248
OCTP
Oxford Cannabinoid Technologies
0 of 5 stars
GBX 0.36
-4.1%
N/A-71.5%£3.87MN/A-53.107Gap Up
IXI
IXICO
0 of 5 stars
GBX 8.75
flat
N/A-57.3%£4.23M£6.67M-437.5089
VAL
ValiRx
0 of 5 stars
GBX 3.50
-3.4%
N/A-67.1%£4.63MN/A-116.678Gap Down
BSFA
BSF Enterprise
0 of 5 stars
GBX 5.25
flat
N/A-68.8%£5.43MN/A-262.5012High Trading Volume
GENF
Genflow Biosciences
0 of 5 stars
GBX 1.58
-2.8%
N/A-62.2%£5.53MN/A-256.005High Trading Volume

Related Companies and Tools

This page (LON:OVB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners